clinical trial · NCT06585579
The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
CervicovaginitisMucogyne Ovule
brief summary
This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.
started
Oct 1, 2024
primary completion
Aug 1, 2025
completion
Nov 1, 2025
last updated
Sep 5, 2024
official title
ORIGYNE (MUCO232) - the Effect of Mucogyne® Ovule on Wound Healing
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol